OTCM
APXZF
Market cap11mUSD
Dec 17, Last price
0.15USD
Name
Carasent ASA
Chart & performance
P/E
—
P/S
0.46
EPS
—
Vol. 1Y
—
Shs. 5Y
13.85%
Rev. 5Y
59.06%
Div Yld LY
—
Div Yld TTM
—
Revenues
244m
+24.95%
Net income
-46m
L
CFO
-4m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Carasent ASA, founded in 1997 and headquartered in Oslo, Norway, delivers cloud-hosted electronic medical record (EMR) and innovative digital healthcare solutions to the healthcare sector across the Nordic region. Its offerings include Webdoc, a comprehensive cloud-native EMR system, and Vårdrummet, an interactive digital platform. Vårdrummet enables healthcare providers to engage with patients through various digital channels such as video consultations and secure chat. The company further provides specialized products including Ad Voca, Ad Opus, and Ad Curis. Previously known as Apptix ASA, the organization officially rebranded to Carasent ASA in May 2019.
Key people
Jesper Jannerberg
Chief Executive Officer · since 2018
Don Hughes
Senior Vice President, Customer Management
Aubrey Smoot
Senior Vice President, Sales & Business Development
Christopher Damvakaris
Vice President, Sales & Business Development
Tom Tighe
Chief Revenue Officer · since 2015
Director · since 2008
Terje Rogne
Director · since 2007
Headquarters & legal address
Rådhusgata 30
Oslo 0151
NO
Oslo 0151
NO
Previous name
APPTIX ASA
Valuation
Title NOK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||